SCHEMBL1104285

SCHEMBL1104285

CCC(SCC(O)CO)C(=O)O

nearest known ligand 0.36

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.36
OR51E2 Q9H255 1/20 0.34
POLB P06746 1/20 0.34
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13446920 1.00 HTT (0.36) HTTOR51E2POLBALDH1A1LMNA
SCHEMBL9060764 0.76
SCHEMBL1104266 0.75 OR51E2 (0.37) OR51E2ALDH1A1LMNA
SCHEMBL107725 0.74 OR51E2 (0.40) OR51E2ALDH1A1LMNA
SCHEMBL6243137 0.73
SCHEMBL5328465 0.70 HTT (0.40) HTTPOLB
SCHEMBL10585381 0.70
SCHEMBL2905803 0.70
SCHEMBL6239079 0.70 HTT (0.40) HTTPOLBALDH1A1
SCHEMBL15135062 0.69 HTT (0.37) HTTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8252296-B2 Aqueous polymer dispersion and use thereof in cosmetics BASF SE (DE) 2012-08-28 US disclosed
US-8151705-B2 Method of preparing lithographic printing plate FUJIFILM CORPORATION (JP) 2012-04-10 US disclosed
US-8151705-B2 Method of preparing lithographic printing plate FUJIFILM CORPORATION (JP) 2012-04-10 US disclosed
US-20100204045-A1 Systemicity Enhancers BASF SE (DE) 2010-08-12 US disclosed
EP-2205097-A1 SYSTEMICITY ENHANCERS BASF SE (DE) 2010-07-14 EP disclosed
US-20100081771-A1 METHOD OF PREPARING LITHOGRAPHIC PRINTING PLATE FUJIFILM CORPORATION (JP) 2010-04-01 US disclosed
US-20100081771-A1 METHOD OF PREPARING LITHOGRAPHIC PRINTING PLATE FUJIFILM CORPORATION (JP) 2010-04-01 US disclosed
EP-2168767-A1 Method of preparing lithographic printing plate Fujifilm Corporation (JP) 2010-03-31 EP disclosed
WO-2009040248-A1 SYSTEMICITY ENHANCERS BASF SE (DE) 2009-04-02 WO disclosed
US-20080194708-A1 Cationic Polymers as Thickeners for Aqueous and Alcoholic Compositions BASF AKTIENGESELLSCHAFT (DE) 2008-08-14 US disclosed
US-20080153925-A1 Use of Amphiphilic Copolymers as Solubilising Agents BASF AKTIENGESELLSCHAFT (DE) 2008-06-26 US disclosed
US-20070197767-A1 Method for producing polymers that are predominantly formed from vinvyl formamide BASF AKTIENGESELLSCHAFT (DE) 2007-08-23 US disclosed
US-20060153793-A1 Aqueous polymer dispersion and use thereof in cosmetics BASF AKTIENGESELLSCHAFT (DE) 2006-07-13 US disclosed
US-20050265950-A1 Cross-linked cationic copolymers comprising regulators, and use therof in cosmetic preparations for hair BASF AKTIENGESELLSCHAFT (DE) 2005-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194708-A1 Cationic Polymers as Thickeners for Aqueous and Alcoholic Compositions ADH1A, ADH1C, PCNA HTT 2123/4885OR51E2 2672/4885POLB 990/4885
US-20060153793-A1 Aqueous polymer dispersion and use thereof in cosmetics ALAD, ACMSD, PADI4 HTT 1180/4885OR51E2 1740/4885POLB 199/4885
US-20080153925-A1 Use of Amphiphilic Copolymers as Solubilising Agents VCL, ASS1, CCNL2 HTT 1373/4885OR51E2 4415/4885POLB 4558/4885
US-20100204045-A1 Systemicity Enhancers C3AR1, C5, CHRM1 HTT 2732/4885OR51E2 2875/4885POLB 3378/4885
US-20050265950-A1 Cross-linked cationic copolymers comprising regulators, and use therof in cosmetic preparations for hair ETF1, MTHFD2, TWF2 HTT 697/4885OR51E2 1845/4885POLB 1391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.